Related Experiment Videos
Enhanced IL-18 expression in common skin tumors
1Department of Dermatology, St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
Immunology Letters
|October 16, 2001
Summary
Interleukin-18 (IL-18) is highly expressed in malignant skin tumors like squamous cell carcinoma and melanoma. This enhanced IL-18 production suggests its significant role in the development and progression of these skin cancers.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Interleukin-18 (IL-18) influences inflammatory responses.
- Previous research indicated IL-18's role in melanoma tumor activity via reactive oxygen intermediates and Fas-ligand expression.
- The role of IL-18 in human skin tumors remained largely unexplored.
Purpose of the Study:
- To investigate the expression pattern of Interleukin-18 (IL-18) in human tumor cell lines.
- To determine the association between IL-18 production and the malignancy of skin tumors, specifically squamous cell carcinoma (SCC) and melanoma.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was employed to quantify IL-18 production.
- Various human tumor cell lines were analyzed, including lymphoma, leukemia, SCC, and melanoma cell lines.
Main Results:
- IL-18 was found to be highly expressed in malignant skin tumor cell lines, including SCC (SK-MES-1) and melanoma (SK-MEL-2, G-361, DM-4, DX-3).
- Enhanced IL-18 expression demonstrated a positive correlation with the malignancy of skin tumors.
- IL-18 production was significantly higher in malignant skin tumors compared to other tested tumor types.
Conclusions:
- Enhanced Interleukin-18 (IL-18) expression is positively correlated with malignant skin tumors, such as squamous cell carcinoma and melanoma.
- IL-18 production by tumor cells in human skin tissue may be a key factor in understanding the pathogenesis of malignant skin tumors.
- IL-18 represents a potential biomarker and therapeutic target for malignant skin cancers.